AAAAAA

   
Results: 1-10 |
Results: 10
FC-2.15, A MONOCLONAL-ANTIBODY ACTIVE AGAINST HUMAN BREAST-CANCER, SPECIFICALLY RECOGNIZES LEWIS(X) HAPTEN
Authors: CAPURRO M BOVER L PORTELA P LIVINGSTON P MORDOH J
Citation: M. Capurro et al., FC-2.15, A MONOCLONAL-ANTIBODY ACTIVE AGAINST HUMAN BREAST-CANCER, SPECIFICALLY RECOGNIZES LEWIS(X) HAPTEN, Cancer immunology and immunotherapy, 45(6), 1998, pp. 334-339
THE HUMAN BREAST-CANCER CELL-LINE IIB-BR-G HAS AMPLIFIED C-MYC AND C-FOS ONCOGENES IN-VITRO AND IS SPONTANEOUSLY METASTATIC IN-VIVO
Authors: BOVER L BARRIO M BRAVO AI SLAVUTSKY I LARRIPA I BOLONDI A AYALA M MORDOH J
Citation: L. Bover et al., THE HUMAN BREAST-CANCER CELL-LINE IIB-BR-G HAS AMPLIFIED C-MYC AND C-FOS ONCOGENES IN-VITRO AND IS SPONTANEOUSLY METASTATIC IN-VIVO, Cellular and molecular biology, 44(3), 1998, pp. 493-504
SUPPRESSION OF SPARC EXPRESSION BY ANTISENSE RNA ABROGATES THE TUMORIGENICITY OF HUMAN-MELANOMA CELLS
Authors: LEDDA MF ADRIS S BRAVO AI KAIRIYAMA C BOVER L CHERNAJOVSKY Y MORDOH J PODHAJCER OL
Citation: Mf. Ledda et al., SUPPRESSION OF SPARC EXPRESSION BY ANTISENSE RNA ABROGATES THE TUMORIGENICITY OF HUMAN-MELANOMA CELLS, Nature medicine, 3(2), 1997, pp. 171-176
ALLOGENEIC CELLS VACCINE INCREASES DISEASE-FREE SURVIVAL IN STAGE-IIIMELANOMA PATIENTS - A NON RANDOMIZED PHASE-II STUDY
Authors: MORDOH J KAIRIYAMA C BOVER L SOLAROLO E
Citation: J. Mordoh et al., ALLOGENEIC CELLS VACCINE INCREASES DISEASE-FREE SURVIVAL IN STAGE-IIIMELANOMA PATIENTS - A NON RANDOMIZED PHASE-II STUDY, Medicina, 57(4), 1997, pp. 421-427
THE EXPRESSION OF THE SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) IS ASSOCIATED WITH THE NEOPLASTIC PROGRESSION OF HUMAN-MELANOMA
Authors: LEDDA F BRAVO AI ADRIS S BOVER L MORDOH J PODHAJCER OL
Citation: F. Ledda et al., THE EXPRESSION OF THE SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) IS ASSOCIATED WITH THE NEOPLASTIC PROGRESSION OF HUMAN-MELANOMA, Journal of investigative dermatology, 108(2), 1997, pp. 210-214
TUMOR-CELLS ENGINEERED TO EXPRESS INTERLEUKIN-6 EXHIBIT A REDUCED TUMORIGENICITY DEPENDING ON THE TUMOR-CELL MODEL
Authors: LEDDA MF ADRIS S BRAVO AI BOVER L CARBONE C PALEOLOG E MORDOH J CHERNAJOVSKY Y PODHAJCER OL
Citation: Mf. Ledda et al., TUMOR-CELLS ENGINEERED TO EXPRESS INTERLEUKIN-6 EXHIBIT A REDUCED TUMORIGENICITY DEPENDING ON THE TUMOR-CELL MODEL, Cellular and molecular biology, 42(5), 1996, pp. 769-778
IDENTIFICATION AND CHARACTERIZATION OF A 14-KDA IMMUNOSUPPRESSIVE PROTEIN-DERIVED FROM IIB-MEL-J, A HUMAN-MELANOMA CELL-LINE
Authors: MORVILLO V BOVER L MORDOH J
Citation: V. Morvillo et al., IDENTIFICATION AND CHARACTERIZATION OF A 14-KDA IMMUNOSUPPRESSIVE PROTEIN-DERIVED FROM IIB-MEL-J, A HUMAN-MELANOMA CELL-LINE, Cellular and molecular biology, 42(5), 1996, pp. 779-795
THE ROLE OF SPARC GENE IN THE TUMORIGENIC CAPACITY OF HUMAN-MELANOMA CELLS
Authors: LEDDA MF ADRIS S BOVER L BRAVO AL MORDOH J PODHAJCER OL
Citation: Mf. Ledda et al., THE ROLE OF SPARC GENE IN THE TUMORIGENIC CAPACITY OF HUMAN-MELANOMA CELLS, Medicina, 56(1), 1996, pp. 51-54
BIOLOGIC, IMMUNOCYTOCHEMICAL, AND CYTOGENETIC CHARACTERIZATION OF 2 NEW HUMAN-MELANOMA CELL-LINES - IIB-MEL-LES AND IIB-MEL-IAN
Authors: KAIRIYAMA C SLAVUTSKY I LARRIPA I MORVILLO V BRAVO AI BOVER L PODHAJCER OL MORDOH J
Citation: C. Kairiyama et al., BIOLOGIC, IMMUNOCYTOCHEMICAL, AND CYTOGENETIC CHARACTERIZATION OF 2 NEW HUMAN-MELANOMA CELL-LINES - IIB-MEL-LES AND IIB-MEL-IAN, Pigment cell research, 8(3), 1995, pp. 121-131
EXPRESSION OF CATHEPSIN-D IN PRIMARY AND METASTATIC HUMAN-MELANOMA AND DYSPLASTIC NEVI
Authors: PODHAJCER OL BOVER L BRAVO AI LEDDA MF KAIRIYAMA C CALB I GUERRA L CAPONY F MORDOH J
Citation: Ol. Podhajcer et al., EXPRESSION OF CATHEPSIN-D IN PRIMARY AND METASTATIC HUMAN-MELANOMA AND DYSPLASTIC NEVI, Journal of investigative dermatology, 104(3), 1995, pp. 340-344
Risultati: 1-10 |